Emergent
Highly Engaged Employees
Highly Engaged EmployeesBlood & Organ Banks · Maryland, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
400 Professional Dr Ste 400, Gaithersbur...Phone Number
(240) 631-3200Website
www.emergentbiosolutions.comRevenue
$676.8 MillionStock Symbol
EBSIndustry
ZI Rank: 24
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
21
17
17
14
21
24
About Emergent
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; RRead more
Emergent Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Emergent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Emergent launches new products
Check if Emergent has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Emergent has new funding data
Earning: See what the market has to say on Emergent recently announced quarterly report
Emergent, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Emergent had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Emergent
Check out if Emergent is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Emergent
Find 3 more new buyers
Compare Similar Companies to Emergent
Compare insights from companies similar to Emergent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Emergent
$676.8M
501-1,000
Public
$62.5M
1998
HA
Howard AndersonSenior Vice President and Chief Information Officer
Company Profile Activity
Activity Insights
Emergent is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Emergent is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Emergent.
Emergent financials insights
Gather financial insights about Emergent, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Stock Offering
$62.5M
Emergent Tech Stack
A closer look at the technologies used by Emergent
Most Recent Scoops
Open Position
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Person-Based
Emergent News & Media
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
GAITHERSBURG, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced it has been awarded a contract modification valued at $52.7 million from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human Services to supply ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) vaccine, ancillaries as well as diluent replacement lots for smallpox preparedness and response needs. Deliveries are expected to begEmergent BioSolutions Inc. (EBS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript
Emergent BioSolutions Inc. (EBS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 2:00 PM EDTCompany ParticipantsJoseph Papa - CEO,...Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resourcesEmergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
GAITHERSBURG, Md., May 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a contract modification valued at approximately $64.5 million from the Administration for Strategic Preparedness and Response (ASPR), a division of the United States Department of Health and Human Services (HHS), for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)]. The modification has been made to the existing 10-year contract with ASPR (75A50119C
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Emergent
Sign Up For FreeTo access detailed company insights
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Viv... Read More
